Instituto de Ciências Biomédicas Abel Salazar da Universidade do Porto(ICBAS-UP) 4050-313;
CINTESIS@RISE for Health Technology and Services Research at The Associate Laboratory RISE–Health Research Network of Medicine of The University of Porto 4200-219;
Laboratory of Pharmacology and Neurobiology–Department of Immuno-physiology and Pharmacology de Ciências Biomédicas Abel Salazar da Universidade do Porto(ICBAS-UP) 4050-313;
Center for Drug Discovery and Innovative Medicines(MedInUP) de Ciências Biomédicas Abel Salazar da Universidade do Porto(ICBAS-UP) 4050-313;
COVID-19; Healthcare systems; LIVER; Portuguese individuals; COMORBIDITIES; Clinical outcomes;